Visterra

Develops antibody-based therapies for kidney and immune-mediated diseases.

BiotechnologyPharmaceuticals visterrainc.com ↗

Company facts

Founded
2007
Employees
105
Headquarters
United States
Type
Private
Funding
Series C · $46.7M · 2017
Subsidiaries
Visterra Singapore International Pte.